-
1
-
-
11044238414
-
-
on behalf of the WFH Laboratory Sciences Committee., 2nd edn. Montréal, Québec, Canada: World Federation of Hemophilia
-
Kitchen S, McCraw A, Echenagucia M, on behalf of the WFH Laboratory Sciences Committee. Diagnosis of Hemophilia and Other Bleeding Disorders: A Laboratory Manual, 2nd edn. Montréal, Québec, Canada: World Federation of Hemophilia, 2010.
-
(2010)
Diagnosis of Hemophilia and Other Bleeding Disorders: A Laboratory Manual
-
-
Kitchen, S.1
McCraw, A.2
Echenagucia, M.3
-
2
-
-
84920262808
-
Chromogenic determination of factor VIII activity in plasma and factor VIII concentrates.
-
Chromogenic Monograph Series. (accessed 2 October 2014).
-
Rosén S, Chiarion Casoni M. Chromogenic determination of factor VIII activity in plasma and factor VIII concentrates. Chromogenic Monograph Series. http://www.coachrom.com/docs/monographien/Monographie_FactorVIII.pdf (accessed 2 October 2014).
-
-
-
Rosén, S.1
Chiarion Casoni, M.2
-
3
-
-
78649982927
-
Discrepancy between one-stage and chromogenic factor VIII activity assay results can lead to misdiagnosis of haemophilia A phenotype
-
Oldenburg J, Pavlova A. Discrepancy between one-stage and chromogenic factor VIII activity assay results can lead to misdiagnosis of haemophilia A phenotype. Hämostaseologie 2010;30:207-11.
-
(2010)
Hämostaseologie
, vol.30
, pp. 207-211
-
-
Oldenburg, J.1
Pavlova, A.2
-
4
-
-
0017142832
-
Relationship of factor VIII-like antigen (VIII AGN) and clot promoting acitivty (VIII AHF) as measured by one- and two-stage assays in patients with liver disease
-
Rogers JS, Eyster E. Relationship of factor VIII-like antigen (VIII AGN) and clot promoting acitivty (VIII AHF) as measured by one- and two-stage assays in patients with liver disease. Br J Haematol 1976;34:655-61.
-
(1976)
Br J Haematol
, vol.34
, pp. 655-661
-
-
Rogers, J.S.1
Eyster, E.2
-
5
-
-
0035982216
-
A Tyr346 Cys substitution in the inter-domain acidic region a1 of FVIII in an individual with FVIII: C assay discrepancy
-
Mumford AD, Laffan M, O'Donnell J, McVey JH, Johnson DJD, Manning RA, Kemball-Cook G. A Tyr346 Cys substitution in the inter-domain acidic region a1 of FVIII in an individual with FVIII: C assay discrepancy. Br J Haematol 2002;118:589-94.
-
(2002)
Br J Haematol
, vol.118
, pp. 589-594
-
-
Mumford, A.D.1
Laffan, M.2
O'Donnell, J.3
McVey, J.H.4
Johnson, D.J.D.5
Manning, R.A.6
Kemball-Cook, G.7
-
6
-
-
0023950035
-
Functional and immunological assays of FVIII in 133 haemophiliacs - characterization of a subgroup of patients with mild haemophilia A and discrepancy in 1- and 2-stage assays
-
Parquet-Gernez A, Mazurier C, Goudemand M. Functional and immunological assays of FVIII in 133 haemophiliacs - characterization of a subgroup of patients with mild haemophilia A and discrepancy in 1- and 2-stage assays. Thromb Haemost 1988;59:202-6.
-
(1988)
Thromb Haemost
, vol.59
, pp. 202-206
-
-
Parquet-Gernez, A.1
Mazurier, C.2
Goudemand, M.3
-
7
-
-
0028022060
-
Familial discrepancy between the one-stage and two-stage factor VIII methods in a subgroup of patients with haemophilia A
-
Duncan EM, Duncan BM, Tunbridge LJ, Lloyd JV. Familial discrepancy between the one-stage and two-stage factor VIII methods in a subgroup of patients with haemophilia A. Br J Haematol 1994;87:846-8.
-
(1994)
Br J Haematol
, vol.87
, pp. 846-848
-
-
Duncan, E.M.1
Duncan, B.M.2
Tunbridge, L.J.3
Lloyd, J.V.4
-
8
-
-
51249089221
-
One-stage and chromogenic FVIII: C assay discrepancy in mild haemophilia A and the relationship with the mutation and bleeding phenotype
-
Cid AR, Calabuig M, Cortina V, Casaña P, Haya S, Moret A, Cabrera N, Aznar JA. One-stage and chromogenic FVIII: C assay discrepancy in mild haemophilia A and the relationship with the mutation and bleeding phenotype. Haemophilia 2008;14:1049-54.
-
(2008)
Haemophilia
, vol.14
, pp. 1049-1054
-
-
Cid, A.R.1
Calabuig, M.2
Cortina, V.3
Casaña, P.4
Haya, S.5
Moret, A.6
Cabrera, N.7
Aznar, J.A.8
-
9
-
-
63049120163
-
Assay discrepancy in mild haemophilia A: entire population study in a National Haemophilia Centre
-
Poulsen AL, Pedersen LH, Hvas AM, Poulsen LH, Thykjaer H, Ingerslev J. Assay discrepancy in mild haemophilia A: entire population study in a National Haemophilia Centre. Haemophilia 2009;15:285-9.
-
(2009)
Haemophilia
, vol.15
, pp. 285-289
-
-
Poulsen, A.L.1
Pedersen, L.H.2
Hvas, A.M.3
Poulsen, L.H.4
Thykjaer, H.5
Ingerslev, J.6
-
10
-
-
84885043719
-
Specific and global coagulation assays in the diagnosis of discrepant mild hemophilia A
-
Bowyer AE, Van Veen JJ, Goodeve AC, Kitchen S, Makris M. Specific and global coagulation assays in the diagnosis of discrepant mild hemophilia A. Haematologica 2013;98:1980-7.
-
(2013)
Haematologica
, vol.98
, pp. 1980-1987
-
-
Bowyer, A.E.1
Van Veen, J.J.2
Goodeve, A.C.3
Kitchen, S.4
Makris, M.5
-
11
-
-
0000332036
-
A method for the study of antihaemophilic globulin inhibitors with reference to six cases
-
Biggs R, Bidwell E. A method for the study of antihaemophilic globulin inhibitors with reference to six cases. Br J Haematol 1959;5:379-95.
-
(1959)
Br J Haematol
, vol.5
, pp. 379-395
-
-
Biggs, R.1
Bidwell, E.2
-
12
-
-
0016853978
-
Proceedings: a more uniform measurement of factor VIII inhibitors
-
Kasper CK, Aledort L, Aronson D, et al. Proceedings: a more uniform measurement of factor VIII inhibitors. Thromb Diath Haemorrh 1975;34:612.
-
(1975)
Thromb Diath Haemorrh
, vol.34
, pp. 612
-
-
Kasper, C.K.1
Aledort, L.2
Aronson, D.3
-
13
-
-
0028837315
-
The Nijmegen modification of the Bethesda assay for factor VIII: C inhibitors: improved specificity and reliability
-
Verbruggen B, Novakova I, Wessels H, Boezeman J, van den Berg M, Mauser-Bunschoten E. The Nijmegen modification of the Bethesda assay for factor VIII: C inhibitors: improved specificity and reliability. Thromb Haemost 1995;73:247-51.
-
(1995)
Thromb Haemost
, vol.73
, pp. 247-251
-
-
Verbruggen, B.1
Novakova, I.2
Wessels, H.3
Boezeman, J.4
van den Berg, M.5
Mauser-Bunschoten, E.6
-
14
-
-
18344405441
-
A detailed comparison of the performance of the standard versus the Nijmegen modification of the Bethesda assay in detecting factor VIII:C inhibitors in the haemophilia A population of Canada. Association of Hemophilia Centre Directors of Canada. Factor VIII/IX Subcommittee of Scientific and Standardization Committee of International Society on Thrombosis and Haemostasis
-
Giles AR, Verbruggen B, Rivard GE, Teitel J, Walker I. A detailed comparison of the performance of the standard versus the Nijmegen modification of the Bethesda assay in detecting factor VIII:C inhibitors in the haemophilia A population of Canada. Association of Hemophilia Centre Directors of Canada. Factor VIII/IX Subcommittee of Scientific and Standardization Committee of International Society on Thrombosis and Haemostasis. Thromb Haemost 1998;79:872-5.
-
(1998)
Thromb Haemost
, vol.79
, pp. 872-875
-
-
Giles, A.R.1
Verbruggen, B.2
Rivard, G.E.3
Teitel, J.4
Walker, I.5
-
15
-
-
84875457053
-
External quality assessment of factor VIII inhibitor assays
-
Bonar RA, Favaloro EJ, Marsden K. External quality assessment of factor VIII inhibitor assays. Semin Thromb Hemost 2013;39:320-6.
-
(2013)
Semin Thromb Hemost
, vol.39
, pp. 320-326
-
-
Bonar, R.A.1
Favaloro, E.J.2
Marsden, K.3
-
16
-
-
0036332155
-
A 4% solution of bovine serum albumin may be used in place of factor VIII: C deficient plasma in the control sample in the Nijmegen modification of the Bethesda factor VIII: C inhibitor assay
-
Verbruggen B, van Heerde W, Novákovà I, Lillicrap D, Giles A. A 4% solution of bovine serum albumin may be used in place of factor VIII: C deficient plasma in the control sample in the Nijmegen modification of the Bethesda factor VIII: C inhibitor assay. Thromb Haemost 2002;88:362-4.
-
(2002)
Thromb Haemost
, vol.88
, pp. 362-364
-
-
Verbruggen, B.1
van Heerde, W.2
Novákovà, I.3
Lillicrap, D.4
Giles, A.5
-
17
-
-
79955072076
-
Development of a new modified Bethesda method for coagulation inhibitors: the Osaka modified Bethesda method
-
Torita S, Suehisa E, Kawasaki T, Toku M, Takeo E, Tomiyama Y. Development of a new modified Bethesda method for coagulation inhibitors: the Osaka modified Bethesda method. Blood Coagul Fibrinolysis 2011;22:185-9.
-
(2011)
Blood Coagul Fibrinolysis
, vol.22
, pp. 185-189
-
-
Torita, S.1
Suehisa, E.2
Kawasaki, T.3
Toku, M.4
Takeo, E.5
Tomiyama, Y.6
-
18
-
-
84859173395
-
Low-titre inhibitors, undetectable by the Nijmegen assay, reduce factor VIII half-life after immune tolerance induction
-
Dardikh M, Albert T, Masereeuw R, Oldenburg J, Novakova I, van Heerde WL, Verbruggen B. Low-titre inhibitors, undetectable by the Nijmegen assay, reduce factor VIII half-life after immune tolerance induction. J Thromb Haemost 2012;10:706-8.
-
(2012)
J Thromb Haemost
, vol.10
, pp. 706-708
-
-
Dardikh, M.1
Albert, T.2
Masereeuw, R.3
Oldenburg, J.4
Novakova, I.5
van Heerde, W.L.6
Verbruggen, B.7
-
19
-
-
80053392494
-
The factor VIII inhibitor assays can be standardized: results of a workshop
-
Verbruggen B, Dardikh M, Polenewen R, Van Duren C, Meijer P. The factor VIII inhibitor assays can be standardized: results of a workshop. J Thromb Haemost 2011;9:2003-8.
-
(2011)
J Thromb Haemost
, vol.9
, pp. 2003-2008
-
-
Verbruggen, B.1
Dardikh, M.2
Polenewen, R.3
Van Duren, C.4
Meijer, P.5
-
20
-
-
84920281198
-
-
Collaborative study on determination of FVIII inhibitors. SSC working party on behalf of the SSC FVIII/IX subcommittee. Unpublished report
-
Raut S. Collaborative study on determination of FVIII inhibitors. SSC working party on behalf of the SSC FVIII/IX subcommittee. Unpublished report, 2005.
-
(2005)
-
-
Raut, S.1
-
21
-
-
84880400881
-
Comparison of clot-based, chromogenic and fluorescence assays for measurement of factor VIII inhibitors in the US Hemophilia Inhibitor Research Study
-
Hemophilia Inhibitor Research Study Investigators
-
Miller CH, Rice AS, Boylan B, Shapiro AD, Lentz SR, Wicklund BM, Kelly FM, Soucie JM; Hemophilia Inhibitor Research Study Investigators. Comparison of clot-based, chromogenic and fluorescence assays for measurement of factor VIII inhibitors in the US Hemophilia Inhibitor Research Study. J Thromb Haemost 2013;11:1300-9.
-
(2013)
J Thromb Haemost
, vol.11
, pp. 1300-1309
-
-
Miller, C.H.1
Rice, A.S.2
Boylan, B.3
Shapiro, A.D.4
Lentz, S.R.5
Wicklund, B.M.6
Kelly, F.M.7
Soucie, J.M.8
-
22
-
-
84920287114
-
-
Influence of assay type (and effect of residual FVIII ± heat inactivation) on the inhibitor titre. Unpublished report
-
Hillarp A. Influence of assay type (and effect of residual FVIII ± heat inactivation) on the inhibitor titre. Unpublished report, 2013.
-
(2013)
-
-
Hillarp, A.1
-
24
-
-
0034974123
-
A collaborative study to establish the 6th International Standard for factor VIII concentrate
-
Raut S, Heath AB, Barrowcliffe TW. A collaborative study to establish the 6th International Standard for factor VIII concentrate. Thromb Haemost 2001;85:1071-8.
-
(2001)
Thromb Haemost
, vol.85
, pp. 1071-1078
-
-
Raut, S.1
Heath, A.B.2
Barrowcliffe, T.W.3
-
25
-
-
8044253418
-
Pharmacokinetic in vivo comparison using 1-stage and chromogenic substrate assays with two formulations of Hemofil-M
-
Lee C, Barrowcliffe T, Bray G, Gomperts E, Hubbard A, Kemball-Cook G, Lilley P, Owens D, Von Tilberg L, Pasi J. Pharmacokinetic in vivo comparison using 1-stage and chromogenic substrate assays with two formulations of Hemofil-M. Thromb Haemost 1996;76:950-6.
-
(1996)
Thromb Haemost
, vol.76
, pp. 950-956
-
-
Lee, C.1
Barrowcliffe, T.2
Bray, G.3
Gomperts, E.4
Hubbard, A.5
Kemball-Cook, G.6
Lilley, P.7
Owens, D.8
Von Tilberg, L.9
Pasi, J.10
-
26
-
-
0035018552
-
Potency estimation of recombinant factor VIII: effect of assay method and standard
-
Hubbard AR, Bevan SA, Weller LJ. Potency estimation of recombinant factor VIII: effect of assay method and standard. Br J Haematol 2001;113:533-6.
-
(2001)
Br J Haematol
, vol.113
, pp. 533-536
-
-
Hubbard, A.R.1
Bevan, S.A.2
Weller, L.J.3
-
27
-
-
0015183855
-
A biological standard for measurement of blood coagulation factor VIII Activity
-
Bangham DR, Biggs R, Brozovic M, Denson KWE, Skegg JL. A biological standard for measurement of blood coagulation factor VIII Activity. Bull World Health Organ 1971;45:337-51.
-
(1971)
Bull World Health Organ
, vol.45
, pp. 337-351
-
-
Bangham, D.R.1
Biggs, R.2
Brozovic, M.3
Denson, K.W.E.4
Skegg, J.L.5
-
28
-
-
0021116739
-
Standardisation of factor VIII: Establishment of a stable reference plasma for factor VIII-related activities
-
Barrowcliffe TW, Tydeman MS, Kirkwood TBL, Thomas DP. Standardisation of factor VIII: Establishment of a stable reference plasma for factor VIII-related activities. Thromb Haemost 1983;50:690-6.
-
(1983)
Thromb Haemost
, vol.50
, pp. 690-696
-
-
Barrowcliffe, T.W.1
Tydeman, M.S.2
Kirkwood, T.B.L.3
Thomas, D.P.4
-
29
-
-
4844226443
-
Collaborative field study on the utility of a BDD factor VIII concentrate standard in the estimation of BDDr Factor VIII: C activity in hemophilic plasma using one-stage clotting assays
-
ReFacto Field Study Participants.
-
Ingerslev J, Jankowski MA, Weston SB, Charles LA, Charles LA; ReFacto Field Study Participants. Collaborative field study on the utility of a BDD factor VIII concentrate standard in the estimation of BDDr Factor VIII: C activity in hemophilic plasma using one-stage clotting assays. J Thromb Haemost 2004;2:623-8.
-
(2004)
J Thromb Haemost
, vol.2
, pp. 623-628
-
-
Ingerslev, J.1
Jankowski, M.A.2
Weston, S.B.3
Charles, L.A.4
Charles, L.A.5
-
30
-
-
0031878077
-
Influence of phospholipids on the assessment of factor VIII activity
-
Mikaelsson M, Oswaldsson U, Sandberg H. Influence of phospholipids on the assessment of factor VIII activity. Haemophilia 1998;4:646-50.
-
(1998)
Haemophilia
, vol.4
, pp. 646-650
-
-
Mikaelsson, M.1
Oswaldsson, U.2
Sandberg, H.3
|